See more : Össur hf. (OSSR.CO) Income Statement Analysis – Financial Results
Complete financial analysis of Cannassure Therapeutics Ltd (CSURE.TA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cannassure Therapeutics Ltd, a leading company in the industry within the sector.
You may be interested
- Digimarc Corporation (DMRC) Income Statement Analysis – Financial Results
- Cross Plus Inc. (3320.T) Income Statement Analysis – Financial Results
- Future Health ESG Corp. (FHLT) Income Statement Analysis – Financial Results
- Globaltrans Investment Plc (GLTR.IL) Income Statement Analysis – Financial Results
- Hengan International Group Company Limited (HEGIF) Income Statement Analysis – Financial Results
Cannassure Therapeutics Ltd (CSURE.TA)
Industry: Biotechnology
Sector: Healthcare
About Cannassure Therapeutics Ltd
Cannassure Therapeutics Ltd cultivates and produces medical cannabis. Its products comprise medical cannabis oils, indoor inflorescences, select inflorescences, value inflorescences, and cannavix. The company was founded in 2016 and is based in Ashdod, Israel.
Unable to fetch income statement for: CSURE.TA
No news found for: CSURE.TA
Source: https://incomestatements.info
Category: Stock Reports